Effects of phenytoin, carbamazepine, and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy

Epilepsia

Volumn 39, Issue 4, 1998, Pages 355-363

  Schumacher, Thekla B ^a   Beck, Heinz ^a   Steinhäuser, Christian ^a   Schramm, Johannes ^a   Elger, Christian E ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Anticonvulsants; Calcium currents; Hippocampal granule cells; Human; Patch clamp

Indexed keywords

CALCIUM CHANNEL; CARBAMAZEPINE; GABAPENTIN; PHENYTOIN;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; DRUG EFFECT; GRANULE CELL; HIPPOCAMPUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TEMPORAL LOBE EPILEPSY;

ACETIC ACIDS; ADULT; AMINES; ANTICONVULSANTS; CALCIUM CHANNELS; CARBAMAZEPINE; CYCLOHEXANECARBOXYLIC ACIDS; DENTATE GYRUS; EPILEPSY, TEMPORAL LOBE; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; HUMANS; MEMBRANE POTENTIALS; NEURONS; PATCH-CLAMP TECHNIQUES; PHENYTOIN; PYRAMIDAL CELLS;

EID: 0031946435     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1998.tb01387.x     Document Type: Article

References (45)

1. Macdonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia 1995;36(suppl 2):S2-12.
2. Meldrum BS. Update on the mechanism of action of antiepileptic drugs. Epilepsia 1996;37(suppl 6):S4-11.
3. White HS. Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs. Epilepsia 1997;38(suppl 1):S9-17.
4. Wadman WJ, Heinemann U, Konnerth A, Neuhaus S. Hippocampal slices of kindled rats reveal calcium involvement in epileptogenesis. Exp Brain Res 1985;57:404-7.
5. Heinemann U, Hamon B. Calcium and epileptogenesis. Exp Brain Res 1986;65:1-10.
6. Yaari Y, Selzer ME, Pincus JH. Phenytoin: mechanisms of its anticonvulsant action. Ann Neurol 1986;20:171-84.
7. Yaari Y, Hamon B, Lux HD. Development of two types of calcium channels in cultured mammalian hippocampal neurons. Science 1987;235:680-2.
8. Twombly DA, Yoshii M, Narahashi T. Mechanisms of calcium channel block by phenytoin. J Pharmacol Exp Ther 1988;246:189-95.
9. Elliott P. Action of antiepileptic and anaesthetic drugs on Na- and Ca-spikes in mammalian non-myelinated axons. Eur J Pharmacol 1990;175:155-63.
10. Rogawski MA, Porter RJ. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 1990;42:223-86.
11. Rock DM, Kelly KM, Macdonald RL. Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons. Epilepsy Res 1993;16:89-98.
12. Taylor CP. Emerging perspectives on the mechanism of action of gabapentin. Neurology 1994;44:S10-6.
13. Honmou O, Kocsis JD, Richerson GB. Gabapentin potentiates the conductance increase induced by nipecotic acid in CA1 pyramidal neurons in vitro. Epilepsy Res 1995;20:193-202.
14. Petroff OAC, Rothman DL, Behar KL, Lamoureux D, Mattson RH. The effect of gabapentin on brain GABA in patients with epilepsy. Ann Neurol 1996;39:95-9.
15. 2δ subunit of a calcium channel. J Biol Chem 1996; 271:5768-76.
16. Wamil AW, McLean MJ, Taylor CP. Multiple cellular actions of gabapentin. Neurology 1991;41(suppl 1):140.
17. Engel JJ. Update on surgical treatment of the epilepsies: summary of the Second International Palm Desert Conference on the Surgical Treatment of the Epilepsies (1992). Neurology 1993;43:1612-27.
18. Hufnagel A, Burr W, Elger CE, Nadstawek J, Hefner G. Localization of the epileptic focus during methohexital-induced anesthesia. Epilepsia 1992;33:271-84.
19. Behrens E, Zentner J, Van Roost D, Hufnagel A, Elger CE, Schramm J. Subdural and depth electrodes in the presurgical evaluation of epilepsy. Acta Neurochir Wien 1994;128:84-7.
20. Margerison JH, Corsellis JA. Epilepsy and the temporal lobes: a clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 1966;89:499-530.
21. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981;391:85-100.
22. Sigworth FJ, Affolter H, Neher E. Design of the EPC-9, a computer-controlled patch clamp amplifier. 2. Software. J Neurosci Methods 1995;56:203-15.
23. Neher E. Correction for liquid junction potentials in patch clamp experiments. Methods Enzymol 1992;207:123-31.
24. 2+ currents in acutely isolated human hippocampal granule cells. J Neurophysiol 1997;77:1526-37.
25. Vajda F, Williams FM, Davidson S, Falconer MA, Breckenbridge A. Human brain, cerebrospinal fluid, and plasma concentrations of diphenylhydantoin and phenobarbital. Clin Pharmacol Ther 1974; 15:597-603.
26. Goldberg MA, Crandall PH. Human brain binding of phenytoin. Neurology 1978;28:881-5.
27. Johannessen SI, Gerna M, Bakke J, Strandjord RE, Marselli PI. CSF concentrations and serum protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients. Br J Clin Pharmacol 1976;3:575-82.
28. Friis ML, Christiansen J, Hvidberg EF. Brain concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients. Eur J Clin Pharmacol 1978;14:47-51.
29. Vollmer K-O, von Hodenberg A, Kölle EU. Pharmacokinetics and metabolism of gabapentin in rat, dog, and man. Arzneimittelforschung 1986;36:830-9.
30. Crill W. Neuronal mechanisms of seizure initiation. Adv Neurol 1980;27:169-84.
31. Williamson A, Spencer DD, Shepherd GM. Comparison between the membrane and synaptic properties of human and rodent dentate granule cells. Brain Res 1993;622:194-202.
32. Wu LG, Saggau P. Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci 1997;20:204-12.
33. Traub RD, Borck C, Colling SB, Jefferys JGR. On the structure of ictal events in vitro. Epilepsia 1996;37:879-91.
34. Coulter DA, Huguenard JR, Prince DA. Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann Neurol 1989;25:582-93.
35. Sayer RJ, Angus MB, Schwindt PC, Crill WE. Calcium currents in acutely isolated human neocortical neurons. J Neurophysiol 1993; 69(5):1596-606.
36. Greenberg DA, Cooper EC, Carpenter CL. Phenytoin interacts with calcium channels in brain membranes. Ann Neurol 1984;16:616-7.
37. 3H]nitrendipine binding and calcium and sodium fluxes in brain. Biochem Pharmacol 1985;34:2187-91.
38. Messing RO, Carpenter CL, Greenberg DA. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists. J Pharmacol Exp Ther 1985;235:407-11.
39. 2+ current in glucagon-secreting tumor cells (ITC-1). Naunyn Schmiedebergs Arch Pharmacol 1992;345:78-84.
40. Zona C, Tancredi V, Palma E, Pirrone GC, Avoli M. Potassium currents in rat cortical neurons in culture are enhanced by the antiepileptic drug carbamazepine. Can J Physiol Pharmacol 1990; 68:545-7.
41. Kito M, Maehara M, Watanabe K. Antiepileptic drugs - calcium current interaction in cultured human neuroblastoma cells. Seizure 1994;3:141-9.
42. Stefani A, Pisani A, De Murtas M, Mercuri NB, Marciani MG, Calabresi P. Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents. Epilepsia 1995;36:997-1002.
43. Calabresi P, De Murtas M, Stefani A, et al. Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission. Epilepsia 1995;36:990-6.
44. + channels induced by phenytoin in brains of genetically seizure-susceptible (El) and control (ddY) mice. Neuroscience 1994;62:803-11.
45. Heinemann U, Draguhn A, Ficker E, Stabel J, Zhang CL. Strategies for the development of drugs for pharmacoresistant epilepsies. Epilepsia 1994;35(suppl 5):S10-21.